Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Wilex Selects GeneDiagnostics to Distribute Cancer Test in China

publication date: Jan 24, 2013
Wilex Inc., a US maker of diagnostic tests, has engaged GeneDiagnostics as its exclusive distributor for the company’s serum HER-2/neu ELISA test in China. Based in Hangzhou, GeneDiagnostics is a CRO/service provider. The biomarker test is used to monitor patients with metastatic breast cancer. It is approved for US and European use; GeneDiagnostics will be responsible for obtaining its China approval. Financial terms of the agreement were not disclosed. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital